CBZ 0.00% 5.2¢ cbio limited

Also note recent RA deals in the market place-Partner/Developer...

  1. 18,493 Posts.
    lightbulb Created with Sketch. 410
    Also note recent RA deals in the market place-



    Partner/Developer Stage Upfront Milestones

    BMS/Alder IIa $85m $964m
    Eli Lilly/Incyte IIa $90m $665m
    AstraZeneca/Rigel IIb $1,100m $1,100m

    Plus additional undisclosed double digit royalties were also paid.

    Then consider that most takeovers in the biotech market occur soon after Phase 2 results.
 
watchlist Created with Sketch. Add CBZ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.